Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Not a forecast

Rules 1.1.0 · as of 14 Sep 2026

Rick Doblin · Said 5 Sep 2017 · doblin-0058

Quote

Not a forecast

“FDA approval for the prescription use of MDMA-assisted psychotherapy for PTSD now depends on fundraising commitments from our supporters, with $25 million needed and $12.5 million already raised or pledged. It also relies on the compassion and therapeutic skill of the 80 co-therapists, most of whom we have newly trained, who will work on our over one dozen Phase 3 sites in the US, Canada, and Israel.”
· From the Desk of Rick Doblin, Ph.D. – Summer 2017 (MAPS Bulletin Vol. 27, No. 2) · own post

Sentences immediately before the census row doblin-0001 ('on track for FDA approval by 2021'). Sets out $25M need and 80 co-therapists at over a dozen Phase 3 sites.

Descriptive, retrospective, or a statement of preference; no future state asserted.

← Earlier · Later → · All statements